Fibrinogen titer and glycemic status in women using contraceptives

Journal of the College of Physicians and Surgeons Pakistan

Volumn 12, Issue 1, 2002, Pages 16-22

  Syed, Sadiqa ^a   Qureshi, Masood A ^a  

^a Fatima Jinnah Dental College   (Pakistan)

Author keywords

Blood glucose; Contraceptives, oral; Fibrinogen

Indexed keywords

ETHINYLESTRADIOL PLUS NORGESTREL; FIBRINOGEN; GLUCOSE; INJECTABLE CONTRACEPTIVE AGENT; LEVONORGESTREL; LOFEMENAL; NORETHISTERONE ENANTATE; ORAL CONTRACEPTIVE AGENT;

ADULT; AGE; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FAMILY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LONG TERM CARE; MEDICAL ASSESSMENT; PAKISTAN; PROSPECTIVE STUDY; SOCIAL CLASS; THROMBOSIS;

EID: 0036209369     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Reproductive health: An international perspective
2. Helping women use the pills
3. Sexuality and reproductive health
4. Population control: An unsolved problem in Pakistan
5. World population data sheet (Wall Chart)
6. Historical review of the combined oral contraceptive pill and injectable progestogens
7. Oral conraceptives
8. Oral Contraceptives - An update
9. The pill and thrombosis: Epidemiological considerations
10. Epidemiology of oral contraceptives and cardiovascular disease
11. Cardiovascular disease and use of oral and injectable progestogen only contraceptives and combined progestogen contraceptives. Results of an international multi-center case control study. World Health Organization study of cardiovascular disease and steroid hormone contraception
12. Prospective study of oral contraceptives and hypertension among women in the United States
13. High blood pressure in women
14. Update oral contraceptive pills
15. Venous thromboembolism disease and combined oral contraceptives: Result of international multi-center case control study. WHO collaborative study of cardiovascular disease and steroid hormone contraception
16. Third generation oral contraceptives and risk of venous thrombotic disorders: An international case study
17. Oral contraceptives and venous thrombosis: Different sensitivities to active protein C. in women using second-and third-generation oral contraceptives
18. Cardiovascular disease and steroid hormone contraception
19. The increased risk of venous thromboembolism and the use of third generation progestogens: Role of bias in observation research
20. Venous thrombosis, oral contraceptives and high factor V111 levels
21. Effects of oral contraceptives on carbohydrate metabolism
22. Clinical aspects of the relationship between oral contraceptives, abnormalities in carbohydrate metabolism and the development of cardiovascular disease
23. Comparative clinical evaluation of the effect on carbohydrate and lipid metabolism of two norethisterone containing hormonal contraceptives
24. Oral contraceptives and coronary heart disease: Modulation of glucose tolerance and plasma lipid risk factors by progestins
25. The Merck Manual of diagnosis and therapy. Gynaecology and obstetrics section
26. Obesity
27. L'hemostase methode d exploration et diagnostic pratique
28. Evaluation of metabolic control in diabetes
29. Classification, diagnostic tests and pathogenesis of type I diabetes mellitus
30. Definition and classification of diabetes mellitus and the new criteria for diagnosis
31. Use of norplant in Pakistan: Two years experience
32. Why family planning matter
33. Do different brands of oral contraceptives differ in their effects in cardiovascular disease. Oral contraceptives and the health of young women
34. A comparative study of the effects on the hemostatic system of two monophasic gestodene oral contraceptives containing 20μg and 30μg ethinyl estradiol
35. Coagulation, thrombosis and contraceptive steroids. Is there a link?
36. Hemorrhagic stroke, overall stroke risk and combined oral contraceptives. Result of an international, multicenter, case control study. WHO collaborative study of cardiovascular disease and steroid hormone contraception
37. Clinical aspects of the relationship between oral contraceptives and abnormalities of hemostatic system, relation to the development of cardiovascular disease
38. Oral contraceptives and renal and retinal complications in young women with insulin dependent diabetes mellitus